Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
doi: 10.1074/jbc.M410345200 184 ZhongJRaoXXuJFYangPWangCY
[1] On dosagepeptide.com these are framed research-use-only
Is there a balance in oxidative-antioxidant status in blood serum of patients with advanced endometriosis
Indeed, GGT1 has been studied in the context of kidney cancer, with pro-tumour and antitumour effects being attributed 54,55,56
Research applications In-vitro modeling of synergistic GHRH/GHRP receptor cross-talk Pre-clinical study of pulsatile GH-secretagogue dynamics Comparative receptor-pathway research (cAMP vs calcium convergence) Reference standard for analytical characterization of blended preparations Key facts Combines a GHRH-receptor analog with a selective GHS-R1a agonist Nominal 5mg + 5mg per-component loading per vial Components act through mechanistically independent, convergent pathways Supplied as a co-lyophilized research powder for in-vitro use Product specifications Class: GHRH analog + GHRP/ghrelin-receptor agonist research blend Also known as: Mod-GRF + Ipamorelin blend Form: Lyophilized powder vial Purity: 99% (HPLC verified) Testing: Independent third-party HPLC + mass spectrometry Documentation: Certificate of analysis per batch Storage: Store lyophilized at -20C
Consider evidence-based metabolic interventions that are currently accessible
US$ 21.91
US$ 25.28
US$ 28.69
US$ 28.17
US$ 24.81
US$ 28.83
US$ 23.22
US$ 21.95
US$ 26.48
US$ 21.09
